ABBV
57
-2
DNB
66
2
HST
58
11
CCI
28
3
O
35
5
IRM
65
2
LYB
37
12
PSA
51
5
KEY
33
-4
FOXA
59
7
AEP
43
3
KR
38
-2
CI
38
-14
GS
52
-7
KMI
69
4
UNP
42
-4
LOW
50
4
BLK
66
2
TXN
46
-2
A
47
6
ABBV
57
-2
DNB
66
2
HST
58
11
CCI
28
3
O
35
5
IRM
65
2
LYB
37
12
PSA
51
5
KEY
33
-4
FOXA
59
7
AEP
43
3
KR
38
-2
CI
38
-14
GS
52
-7
KMI
69
4
UNP
42
-4
LOW
50
4
BLK
66
2
TXN
46
-2
A
47
6
Financhill
Back

InspireMD Vs. Perspective Therapeutics Industry Stock Comparison

Buy
52

NSPR
InspireMD

Last Price:
2.45
Seasonality Move:
0.01%
Sell
30

CATX
Perspective Therapeutics

Last Price:
11.98
Seasonality Move:
26.28%
Buy
52
InspireMD (NSPR) is a Buy

Is InspireMD a Buy, Sell or Hold?

  • The current InspireMD [NSPR] share price is $2.47. The Score for NSPR is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • NSPR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $12.19. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NSPR Stock Price Chart

What is InspireMD's stock price today?

  • The InspireMD share price today is $2.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NSPR is experiencing selling pressure, which indicates risk of future bearish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $12.19
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.

NSPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 38.9 Sell
Chaikin Money Flow: -17042 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.46 - 2.64) Sell
Bollinger Bands (100): (2.46 - 2.86) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.38 Sell
Relative Strength Index (14 RSI): 46.93 Sell
Chaikin Money Flow: -154562 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.92 - 13.12) Sell
Bollinger Bands (100): (11.23 - 14.35) Sell

NSPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.47 Buy
20-day SMA: 2.53 Sell
50-day SMA: 2.65 Sell
200-day SMA: 2.57 Sell
8-day EMA: 2.48 Sell
20-day EMA: 2.52 Sell
50-day EMA: 2.6 Sell
200-day EMA: 2.6 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.85 Buy
20-day SMA: 12.37 Sell
50-day SMA: 13.45 Sell
200-day SMA: 12.59 Sell
8-day EMA: 12 Buy
20-day EMA: 12.31 Sell
50-day EMA: 12.84 Sell
200-day EMA: 11.76 Buy

InspireMD Earnings Growth & NSPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and an increase next year of $0.11 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.17 per share.

InspireMD Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):